Ovid Therapeutics
Patents, Design & Utilities

Last updated:

List of all Ovid Therapeutics patents 59 in total

Status Patent
Application
Utility: USE OF GABOXADOL IN THE TREATMENT OF SUBSTANCE USE DISORDERS External link
Filling date: 5 Sep 2025 Issue date: 4 Aug 2022
Grant
Utility: Gaboxadol for therapeutic treatment of 1p36 deletion syndrome External link
Filling date: 5 Sep 2025 Issue date: 21 Jun 2022
Application
Utility: USE OF GABOXADOL, GANAXOLONE AND ALLOPREGNANOLONE TO TREAT MOVEMENT DISORDERS External link
Filling date: 5 Sep 2025 Issue date: 14 Apr 2022
Grant
Utility: Use of gaboxadol in the treatment of diabetes and related conditions External link
Filling date: 5 Sep 2025 Issue date: 5 Apr 2022
Grant
Utility: Methods for treating aggression associated with Alzheimer's disease External link
Filling date: 5 Sep 2025 Issue date: 22 Mar 2022
Application
Utility: PHARMACEUTICAL FORMULATIONS CONTAINING GABOXADOL FOR THERAPEUTIC TREATMENT External link
Filling date: 5 Sep 2025 Issue date: 10 Feb 2022
Application
Utility: METHODS OF INCREASING TONIC INHIBITION AND TREATING SECONDARY INSOMNIA External link
Filling date: 5 Sep 2025 Issue date: 20 Jan 2022
Application
Utility: TREATMENT OF DEPRESSIVE DISORDERS External link
Filling date: 5 Sep 2025 Issue date: 9 Dec 2021
Application
Utility: RECOMBINANT ADENO-ASSOCIATED VECTORS External link
Filling date: 5 Sep 2025 Issue date: 2 Dec 2021
Grant
Utility: Use of MIR-92A or MIR-145 in the treatment of Angelman syndrome External link
Filling date: 5 Sep 2025 Issue date: 28 Sep 2021
Application
Utility: METHODS OF TREATING ATTENTION DEFICIT HYPERACTIVITY DISORDER External link
Filling date: 5 Sep 2025 Issue date: 16 Sep 2021
Grant
Utility: Methods of treating developmental disorders with gaboxadol External link
Filling date: 5 Sep 2025 Issue date: 24 Aug 2021
Grant
Utility: Use of gaboxadol for the treatment of Tourette syndrome, tics and stuttering External link
Filling date: 5 Sep 2025 Issue date: 17 Aug 2021
Application
Utility: METHODS AND COMPOSITIONS FOR TREATMENT OF EPILEPTIC DISORDERS External link
Filling date: 5 Sep 2025 Issue date: 15 Jul 2021
Application
Utility: GABOXADOL FOR THERAPEUTIC TREATMENT OF 1p36 DELETION SYNDROME External link
Filling date: 5 Sep 2025 Issue date: 24 Jun 2021
Application
Utility: USE OF GABOXADOL IN THE TREATMENT OF GASTROINTESTINAL TRACT DISORDERS AND ASTHMA External link
Filling date: 5 Sep 2025 Issue date: 17 Jun 2021
Application
Utility: USE OF (S)-3-AMINO-4-(DIFLUOROMETHYLENYL) CYCLOPENT-1-ENE-1-CARBOXYLIC ACID AND RELATED COMPOUNDS, (1S,3S)-3-AMINO-4-(DIFLUOROMETHYLIDENE) CYCLOPENTANE-1-CARBOXYLIC ACID AND VIGABATRIN IN THE TREATMENT OF DEVELOPMENTAL DISORDERS External link
Filling date: 5 Sep 2025 Issue date: 8 Apr 2021
Application
Utility: USE OF MIR101 OR MIR128 IN THE TREATMENT OF SEIZURE DISORDERS External link
Filling date: 5 Sep 2025 Issue date: 1 Apr 2021
Grant
Utility: Methods of treating developmental disorders and/or seizure disorders with etifoxine External link
Filling date: 5 Sep 2025 Issue date: 23 Feb 2021
Application
Utility: USE OF GABOXADOL IN THE TREATMENT OF DIABETES AND RELATED CONDITIONS External link
Filling date: 5 Sep 2025 Issue date: 4 Feb 2021
Application
Utility: METHODS OF TREATING DEVELOPMENTAL DISORDERS WITH GABOXADOL External link
Filling date: 5 Sep 2025 Issue date: 4 Feb 2021
Application
Utility: PHARMACEUTICAL FORMULATIONS CONTAINING GABOXADOL FOR THERAPEUTIC TREATMENT External link
Filling date: 5 Sep 2025 Issue date: 21 Jan 2021
Application
Utility: METHODS AND COMPOSITIONS FOR TREATMENT OF EPILEPTIC DISORDERS External link
Filling date: 5 Sep 2025 Issue date: 7 Jan 2021
Grant
Utility: Use of MIR101 or MIR128 in the treatment of seizure disorders External link
Filling date: 5 Sep 2025 Issue date: 22 Dec 2020
Application
Utility: USE OF GABOXADOL FOR THE TREATMENT OF TOURETTE SYNDROME, TICS AND STUTTERING External link
Filling date: 5 Sep 2025 Issue date: 3 Dec 2020
Grant
Utility: Use of (s)-3-amino-4-(difluoromethylenyl) cyclopent-1-ene-l-carboxylic acid and related compounds, (1s,3S)-3-amino-4-(difluoromethylidene) cyclopentane-1-carboxylic acid and vigabatrin in the treatment of developmental disorders External link
Filling date: 5 Sep 2025 Issue date: 27 Oct 2020
Grant
Utility: Use of Gaboxadol in the treatment of diabetes and related conditions External link
Filling date: 5 Sep 2025 Issue date: 27 Oct 2020
Application
Utility: USE OF MIR-92A OR MIR-145 IN THE TREATMENT OF ANGELMAN SYNDROME External link
Filling date: 5 Sep 2025 Issue date: 22 Oct 2020
Grant
Utility: Methods and compositions for treatment of epileptic disorders External link
Filling date: 5 Sep 2025 Issue date: 13 Oct 2020
Grant
Utility: Use of gaboxadol for the treatment of Tourette syndrome, tics and stuttering External link
Filling date: 5 Sep 2025 Issue date: 8 Sep 2020
Grant
Utility: Methods of treating developmental encephalopathies External link
Filling date: 5 Sep 2025 Issue date: 8 Sep 2020
Grant
Utility: Methods of treating developmental syndromes with PDE10A inhibitors External link
Filling date: 5 Sep 2025 Issue date: 11 Aug 2020
Application
Utility: USE OF (1S,3S)-3-AMINO-4-(DIFLUOROMETHYLIDENE) CYCLOPENTANE-1-CARBOXYLIC ACID AND (S)-3-AMINO-4-(DIFLUOROMETHYLENYL)CYCLOPENT-1-ENE-1-CARBOXYLIC ACID IN THE TREATMENT OF TINNITUS, ACUTE SENSORINEURAL HEARING LOSS, MENIERE'S DISEASE, TOURETTE'S SYNDROME, ATTENTION DEFICIT HYPERACTIVITY DISORDER AND ADDICTION External link
Filling date: 5 Sep 2025 Issue date: 6 Aug 2020
Application
Utility: USE OF GABOXADOL IN THE TREATMENT OF NARCOLEPSY External link
Filling date: 5 Sep 2025 Issue date: 16 Jul 2020
Grant
Utility: Use of MIR-92A or MIR-145 in the treatment of Angelman syndrome External link
Filling date: 5 Sep 2025 Issue date: 7 Jul 2020
Application
Utility: USE OF GABOXADOL FOR THE TREATMENT OF NON-24 HOUR SLEEP-WAKE DISORDER External link
Filling date: 5 Sep 2025 Issue date: 18 Jun 2020
Application
Utility: TREATMENT OF DEPRESSIVE DISORDERS External link
Filling date: 5 Sep 2025 Issue date: 11 Jun 2020
Application
Utility: METHODS AND COMPOSITIONS FOR TREATMENT OF EPILEPTIC DISORDERS External link
Filling date: 5 Sep 2025 Issue date: 11 Jun 2020
Grant
Utility: Use of (1S,3S)-3-amino-4-(difluoromethylidene) cyclopentane-1-carboxylic acid and (S)-3-amino-4-(difluoromethylenyl)cyclopent-1-ene-1-carboxylic acid in the treatment of tinnitus, acute sensorineural hearing loss, meniere'S disease, tourette'S syndrome, attention deficit hyperactivity disorder and addiction External link
Filling date: 5 Sep 2025 Issue date: 19 May 2020
Application
Utility: USE OF GABOXADOL, GANAXOLONE AND ALLOPREGNANOLONE TO TREAT MOVEMENT DISORDERS External link
Filling date: 5 Sep 2025 Issue date: 7 May 2020
Grant
Utility: Methods and compositions for treatment of epileptic disorders External link
Filling date: 5 Sep 2025 Issue date: 31 Mar 2020
Application
Utility: USE OF GABOXADOL FOR THE TREATMENT OF TOURETTE SYNDROME, TICS AND STUTTERING External link
Filling date: 5 Sep 2025 Issue date: 26 Mar 2020
Application
Utility: METHODS OF TREATING DEVELOPMENTAL DISORDERS AND/OR SEIZURE DISORDERS WITH ETIFOXINE External link
Filling date: 5 Sep 2025 Issue date: 2 Jan 2020
Application
Utility: METHODS OF TREATING SEIZURE DISORDERS AND PRADER-WILLI SYNDROME External link
Filling date: 5 Sep 2025 Issue date: 2 Jan 2020
Application
Utility: USE OF MIR-92A OR MIR-145 IN THE TREATMENT OF ANGELMAN SYNDROME External link
Filling date: 5 Sep 2025 Issue date: 19 Dec 2019
Application
Utility: USE OF (S)-3-AMINO-4-(DIFLUOROMETHYLENYL) CYCLOPENT-1-ENE-1-CARBOXYLIC ACID AND RELATED COMPOUNDS, (1S,3S)-3-AMINO-4-(DIFLUOROMETHYLIDENE) CYCLOPENTANE-1-CARBOXYLIC ACID AND VIGABATRIN IN THE TREATMENT OF DEVELOPMENTAL DISORDERS External link
Filling date: 5 Sep 2025 Issue date: 12 Dec 2019
Grant
Utility: Methods of treating behavioral syndromes using pipradrol External link
Filling date: 5 Sep 2025 Issue date: 3 Dec 2019
Application
Utility: METHODS OF TREATING ATTENTION DEFICIT HYPERACTIVITY DISORDER External link
Filling date: 5 Sep 2025 Issue date: 21 Nov 2019
Application
Utility: METHODS OF TREATING DEVELOPMENTAL DISORDERS AND/OR SEIZURE DISORDERS WITH FLUPIRTINE External link
Filling date: 5 Sep 2025 Issue date: 31 Oct 2019
Application
Utility: METHODS OF TREATING DEVELOPMENTAL DISORDERS WITH GABOXADOL External link
Filling date: 5 Sep 2025 Issue date: 24 Oct 2019

Showing 1 to 50 of 59 patents.